» Articles » PMID: 17512057

Methodological Considerations for Gene Expression Profiling of Human Brain

Abstract

Gene expression profiles of postmortem brain tissue represent important resources for understanding neuropsychiatric illnesses. The impact(s) of quality covariables on the analysis and results of gene expression studies are important questions. This paper addressed critical variables which might affect gene expression in two brain regions. Four broad groups of quality indicators in gene expression profiling studies (clinical, tissue, RNA, and microarray quality) were identified. These quality control indicators were significantly correlated, however one quality variable did not account for the total variance in microarray gene expression. The data showed that agonal factors and low pH correlated with decreased integrity of extracted RNA in two brain regions. These three parameters also modulated the significance of alterations in mitochondrial-related genes. The average F-ratio summaries across all transcripts showed that RNA degradation from the AffyRNAdeg program accounted for higher variation than all other quality factors. Taken together, these findings confirmed prior studies, which indicated that quality parameters including RNA integrity, agonal factors, and pH are related to differences in gene expression profiles in postmortem brain. Individual candidate genes can be evaluated with these quality parameters in post hoc analysis to help strengthen the relevance to psychiatric disorders. We find that clinical, tissue, RNA, and microarray quality are all useful variables for collection and consideration in study design, analysis, and interpretation of gene expression results in human postmortem studies.

Citing Articles

The influence of tissue pH and RNA integrity number on gene expression of human postmortem brain.

Miyahara K, Hino M, Yu Z, Ono C, Nagaoka A, Hatano M Front Psychiatry. 2023; 14:1156524.

PMID: 37520228 PMC: 10379646. DOI: 10.3389/fpsyt.2023.1156524.


Neurotransmission-related gene expression in the frontal pole is altered in subjects with bipolar disorder and schizophrenia.

Medina A, Hagenauer M, Krolewski D, Hughes E, Thew Forrester L, Walsh D Transl Psychiatry. 2023; 13(1):118.

PMID: 37031222 PMC: 10082811. DOI: 10.1038/s41398-023-02418-1.


A Sensitization-Free Dimethyl Fumarate Prodrug, Isosorbide Di-(Methyl Fumarate), Provides a Topical Treatment Candidate for Psoriasis.

Bojanowski K, Ibeji C, Singh P, Swindell W, Chaudhuri R JID Innov. 2021; 1(4):100040.

PMID: 34909741 PMC: 8659395. DOI: 10.1016/j.xjidi.2021.100040.


Agonal Factors Distort Gene-Expression Patterns in Human Postmortem Brains.

Dai J, Chen Y, Dai R, Jiang Y, Tian J, Liu S Front Neurosci. 2021; 15:614142.

PMID: 33841074 PMC: 8027124. DOI: 10.3389/fnins.2021.614142.


Pathology and Biobanking.

Kelten Talu C, Toper M, Sahin Y, Erdogdu I Turk Patoloji Derg. 2020; 36(2):93-108.

PMID: 32189322 PMC: 10511253. DOI: 10.5146/tjpath.2020.01482.


References
1.
Johnston N, Cervenak J, Shore A, Torrey E, Yolken R, Cerevnak J . Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium. J Neurosci Methods. 1997; 77(1):83-92. DOI: 10.1016/s0165-0270(97)00115-5. View

2.
Dai M, Wang P, Boyd A, Kostov G, Athey B, Jones E . Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 2005; 33(20):e175. PMC: 1283542. DOI: 10.1093/nar/gni179. View

3.
Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E . Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res. 2005; 33(6):e56. PMC: 1072807. DOI: 10.1093/nar/gni054. View

4.
Wilusz C, Wilusz J . Bringing the role of mRNA decay in the control of gene expression into focus. Trends Genet. 2004; 20(10):491-7. DOI: 10.1016/j.tig.2004.07.011. View

5.
Yates C, Butterworth J, Tennant M, Gordon A . Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem. 1990; 55(5):1624-30. DOI: 10.1111/j.1471-4159.1990.tb04948.x. View